Characterization of novel elongated Parvulin isoforms that are ubiquitously expressed in human tissues and originate from alternative transcription initiation
2006

Study of New Parvulin Isoforms in Humans

publication Evidence: moderate

Author Information

Author(s): Jonathan Mueller, Daniel Kessler, Daniel Neumann, Tina Stratmann, Panagiotis Papatheodorou, Cristina Hartmann-Fatu, Peter Bayer

Primary Institution: University of Duisburg and Essen

Hypothesis

The study investigates the existence and characteristics of a longer Parvulin isoform expressed in human tissues.

Conclusion

The study identifies a novel Parvulin isoform, Par17, which is expressed in human tissues and may have different functions compared to the well-characterized Par14.

Supporting Evidence

  • The longer Parvulin isoform contains a 5' extension with two SNPs leading to amino acid substitutions.
  • About 1% of all Parvulin mRNAs include the novel extension as quantified by real-time PCR.
  • The human Parvulin promoter is TATA-less and situated in a CpG island typical for housekeeping genes.

Takeaway

Scientists found a new version of a protein called Parvulin that is present in human cells and might work differently than the known version.

Methodology

The study used RT-PCR and real-time PCR to confirm the existence of the longer Parvulin isoform and to quantify its expression in various human tissues.

Digital Object Identifier (DOI)

10.1186/1471-2199-7-9

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication